Wealthspan Partners LLC Sells 125 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Wealthspan Partners LLC trimmed its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 12.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 865 shares of the biotechnology company’s stock after selling 125 shares during the period. Wealthspan Partners LLC’s holdings in Axon Enterprise were worth $514,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also added to or reduced their stakes in AXON. Groupama Asset Managment purchased a new stake in shares of Axon Enterprise in the third quarter valued at approximately $200,000. Massachusetts Financial Services Co. MA bought a new stake in Axon Enterprise during the 3rd quarter valued at $120,553,000. International Assets Investment Management LLC purchased a new stake in shares of Axon Enterprise in the 3rd quarter worth $871,860,000. Westfield Capital Management Co. LP grew its position in shares of Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after buying an additional 127,769 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its stake in shares of Axon Enterprise by 328.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after buying an additional 111,405 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Insider Activity at Axon Enterprise

In related news, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now directly owns 2,392 shares of the company’s stock, valued at $1,631,487.52. This represents a 34.52 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the sale, the president now directly owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock valued at $30,721,337 in the last three months. 5.70% of the stock is owned by insiders.

Axon Enterprise Trading Down 0.2 %

Axon Enterprise stock opened at $652.18 on Monday. Axon Enterprise, Inc. has a one year low of $247.04 and a one year high of $698.67. The stock has a market cap of $49.73 billion, a PE ratio of 168.52, a price-to-earnings-growth ratio of 6.54 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a 50-day moving average of $619.63 and a two-hundred day moving average of $483.68.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on AXON. Needham & Company LLC upped their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Finally, Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $524.85.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.